FDA Death Panels

Doug Ross has the news, "Berwick's First Strike: Susan G. Komen Foundation and Ovarian Cancer Alliance Decry First-Ever Medicare Denials of FDA-Approved Cancer Drugs."

Ann Althouse asks if these are "death panels"? And the response:

If Avastin is what stands between you and death, then yes, "Death Panel" is an "appropriate statement" and yes, it is appropriate to cause alarm.

Full disclosure. I have advanced ovarian cancer. Hello friends and relatives.

The statistics for my stage of ovarian cancer (Stage IIIc) project an 18% survival rate two years after diagnosis.

I took part in a clinical trial for Avastin. My provider recently revealed to me that I received the test drug.

I am approaching that two-year mark of initial diagnosis, and so far, I am doing well. I attribute that good result to Avastin, which prevents the regeneration of cancer cells. Yeah, I had some lousy side effects, but it seems to have worked.

Thank you, and good night, Irene.